BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11857352)

  • 21. Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.
    Rashed HE; Abdelrahman AE; Abdelgawad M; Balata S; Shabrawy ME
    Turk Patoloji Derg; 2017; 1(1):211-222. PubMed ID: 28832075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD47 expression in Epstein-Barr virus-associated gastric carcinoma: coexistence with tumor immunity lowering the ratio of CD8
    Abe H; Saito R; Ichimura T; Iwasaki A; Yamazawa S; Shinozaki-Ushiku A; Morikawa T; Ushiku T; Yamashita H; Seto Y; Fukayama M
    Virchows Arch; 2018 Apr; 472(4):643-651. PubMed ID: 29536167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer.
    Bennett MW; O'connell J; O'sullivan GC; Roche D; Brady C; Kelly J; Collins JK; Shanahan F
    Gut; 1999 Feb; 44(2):156-62. PubMed ID: 9895372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer.
    Wang K; Shen T; Siegal GP; Wei S
    Hum Pathol; 2017 Nov; 69():110-117. PubMed ID: 28993275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative IL-2 immunotherapy enhances tumor infiltrating lymphocytes (TILs) in gastric cancer patients.
    Romano F; Cesana G; Caprotti R; Bovo G; Uggeri F; Piacentini MG; Crippa S; Uggeri F
    Hepatogastroenterology; 2006; 53(70):634-8. PubMed ID: 16995478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoregulatory function of HLA-G in gastric cancer.
    Tuncel T; Karagoz B; Haholu A; Ozgun A; Emirzeoglu L; Bilgi O; Kandemir EG
    Asian Pac J Cancer Prev; 2013; 14(12):7681-4. PubMed ID: 24460353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differing phenotypes between intraepithelial and stromal lymphocytes in early-stage tongue cancer.
    Katou F; Ohtani H; Watanabe Y; Nakayama T; Yoshie O; Hashimoto K
    Cancer Res; 2007 Dec; 67(23):11195-201. PubMed ID: 18056444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of Fas ligand in gastric carcinoma relates to lymph node metastasis.
    Nagashima H; Mori M; Sadanaga N; Mashino K; Yoshikawa Y; Sugimachi K
    Int J Oncol; 2001 Jun; 18(6):1157-62. PubMed ID: 11351245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune-checkpoint status in penile squamous cell carcinoma: a North American cohort.
    Cocks M; Taheri D; Ball MW; Bezerra SM; Del Carmen Rodriguez M; Ricardo BFP; Bivalacqua TJ; Sharma RB; Meeker A; Chaux A; Burnett AL; Netto GJ
    Hum Pathol; 2017 Jan; 59():55-61. PubMed ID: 27663086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma.
    Workel HH; Komdeur FL; Wouters MC; Plat A; Klip HG; Eggink FA; Wisman GB; Arts HJ; Oonk MH; Mourits MJ; Yigit R; Versluis M; Duiker EW; Hollema H; de Bruyn M; Nijman HW
    Eur J Cancer; 2016 Jun; 60():1-11. PubMed ID: 27038842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-dose interleukin-2 administered pre-operatively to patients with gastric cancer activates peripheral and peritumoral lymphocytes but does not affect prognosis.
    Cesana GC; Romano F; Piacentini G; Scotti M; Brenna A; Bovo G; Vaghi M; Aletti G; Caprotti R; Kaufman H; Uggeri F
    Ann Surg Oncol; 2007 Apr; 14(4):1295-304. PubMed ID: 17225981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infiltration of CD8+ lymphocytes is an independent prognostic factor of biochemical failure-free survival in prostate cancer.
    Ness N; Andersen S; Valkov A; Nordby Y; Donnem T; Al-Saad S; Busund LT; Bremnes RM; Richardsen E
    Prostate; 2014 Oct; 74(14):1452-61. PubMed ID: 25111810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of Tn and sialyl-Tn antigens in endometrial cancer: its relationship with tumor-produced cyclooxygenase-2, tumor-infiltrated lymphocytes and patient prognosis.
    Ohno S; Ohno Y; Nakada H; Suzuki N; Soma G; Inoue M
    Anticancer Res; 2006; 26(6A):4047-53. PubMed ID: 17195456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast.
    Rathore AS; Kumar S; Konwar R; Makker A; Negi MP; Goel MM
    Indian J Med Res; 2014 Sep; 140(3):361-9. PubMed ID: 25366203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
    Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.
    Gabrielson A; Wu Y; Wang H; Jiang J; Kallakury B; Gatalica Z; Reddy S; Kleiner D; Fishbein T; Johnson L; Island E; Satoskar R; Banovac F; Jha R; Kachhela J; Feng P; Zhang T; Tesfaye A; Prins P; Loffredo C; Marshall J; Weiner L; Atkins M; He AR
    Cancer Immunol Res; 2016 May; 4(5):419-30. PubMed ID: 26968206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of PD-L1 expression and CD8+ T cell infiltration in pulmonary neuroendocrine tumors.
    Wang H; Li Z; Dong B; Sun W; Yang X; Liu R; Zhou L; Huang X; Jia L; Lin D
    Diagn Pathol; 2018 May; 13(1):30. PubMed ID: 29789013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of tumor PD-L1 expression combined with CD8
    Wang Q; Lou W; Di W; Wu X
    Int Immunopharmacol; 2017 Nov; 52():7-14. PubMed ID: 28846888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PD-L1 Expression and CD8
    Wang Y; Zhu C; Song W; Li J; Zhao G; Cao H
    J Immunol Res; 2018; 2018():4180517. PubMed ID: 30003113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Density of CD8-positive tumor-infiltrating T-lymphocytes is an independent prognostic factor in adenocarcinoma of the esophagogastric junction.
    Knief J; Lazar-Karsten P; Wellner U; Hummel R; Thorns C
    Histol Histopathol; 2019 Oct; 34(10):1121-1129. PubMed ID: 30938449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.